POCT(ポイントオブケア検査)デバイスのアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2024年)

【英語タイトル】Asia-Pacific POCT Device Market Analysis : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Data Bridge Market Researchが出版した調査資料(DBMR810234)・商品コード:DBMR810234
・発行会社(調査会社):Data Bridge Market Research
・発行日:2017年10月
・ページ数:150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アジア太平洋
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥345,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、POCT(ポイントオブケア検査)デバイスのアジア太平洋市場について調査・分析し、POCT(ポイントオブケア検査)デバイスのアジア太平洋市場動向、市場予測、セグメント別分析、POCT(ポイントオブケア検査)デバイス市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

In this region, Asia-Pacific POCT device market is projected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. Based on geography, the Asia-Pacific POCT market is segmented into 11 geographical regions, such as,
Japan,

China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of Asia-Pacific.
Asia-Pacific POCT market competition by top players including -
F. Hoffmann La Roche Diagnostics Limited is dominating the Asia-Pacific POCT device market major players followed by Abbott,
Alere Inc.,
Siemens AG,
Becton, Dickinson and Company,
Johnson & Johnson Services Inc.,
PTS Diagnostics,
Instrumentation Laboratory,
Nova Biomedical,
Beckman Coulter, Inc.,
Werfenlife
The Asia-Pacific POCT device market is segmented on the basis of product type, prescription mode, distribution channel, end user, and geography.
The Asia-Pacific POCT device market is segmented into twelve product types, such asblood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing.
Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, and respiratory infections testing kit.
Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
On the basis of prescription mode, the Asia-Pacific point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the Asia-Pacific point-of-care testing market is segmented into direct tenders and retail.
On the basis of end users, the Asia-Pacific point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.

【レポートの目次】

Table Of Contents

1. Introduction 17
1.1. Objectives Of The Study 17
1.2. Market Definition 17
1.3. Overview Of Asia-Pacific Point-Of-Care Testing Market 18
1.4. Currency And Pricing 19
1.5. Limitation 19
1.6. Markets Covered 20
2. Market Segmentation 22
2.1. Markets Covered 22
2.2. Geographic Scope 23
2.3. Years Considered For The Study 24
2.4. Currency And Pricing 24
2.5. Research Methodology 25
2.6. Primary Interviews With Key Opinion Leaders 29
2.7. Secondary Source 30
2.8. Assumptions 30
3. Market Overview 31
3.1. Drivers 33
3.1.1. Increase In Chronic And Infectious Diseases 33
3.1.2. Advancement Of Technology 34
3.2. Restraints 35
3.2.1. Rising Cost Of Poct Tests 35
3.2.2. Low Reimbursement Scenario 35
3.3. Opportunities 36
3.3.1. Scope For Unmet Medical Needs 36
3.3.2. Emerging Poct Device Market 36
3.4. Threats 37
3.4.1. Lack Of Accuracy And Threats 37
3.4.2. Testing Performed By Non Laboratory Personnel And Lack Of Awareness Among The Users 38
4. Executive Summary 39
5. Premium Insights 42
6. Asia-Pacific Point-Of-Care Testing Market: Regulatory Scenario 45
6.1. Overview 45
6.1.1. Regulatory Procedure: 45
6.2. Cfda 46
6.3. Tga 47
6.4. India (Cdsco) 48
6.5. Japan (Mhlw) 49
7. Asia-Pacific Point-Of-Care Testing Market: Reimbursement Scenario 51
7.1. Overview 51
8. Asia-Pacific Point-Of-Care Testing Market, By Product Type 52
8.1. Overview 53
8.2. Cardiometabolic Monitoring Kits 56
8.2.1. Cardiac Markers 59
8.2.2. Blood Gas Electrolyte Testing Kits 59
8.2.3. Hba1C Testing Kits 60
8.2.4. Lipid Testing Kits 60
8.3. Infectious Disease Testing Kits 61
8.3.1. Influenza Testing Kits 64
8.3.2. Hiv Testing Kits 64
8.3.3. Hepatitis Testing Kits 65
8.3.4. Std Testing Kits 65
8.3.5. Tropical Diseases Testing Kits 66
8.3.6. Healthcare Associated Testing Kits 66
8.3.7. Respiratory Infections Testing Kits 67
8.4. Cholesterol Testing Kits 68
8.4.1. Prothrombin Time Testing Kits 71
8.4.2. Activated Clotting Time Testing Kits 71
8.5. Blood Glucose Testing Kits 72
8.6. Pregnancy And Fertility Testing Kits 74
8.7. Tumor Cancer Markers 76
8.8. Urinalysis Testing Kits 78
8.9. Hematology Testing Kits 80
8.10. Drugs Of Abuse Testing Kits 82
8.11. Fecal Occult Testing Kits 84
8.12. Rapid Coagulation Testing Kits 85
9. Asia-Pacific Point-Of-Care Testing Market, By Distribution Channel 87
9.1. Overview 88
9.1.1. Direct Tender 90
9.1.2. Retail Pharmacy 92
10. Asia-Pacific Point-Of-Care Testing Market, By End User 94
10.1. Overview 95
10.2. Asia-Pacific Poct Market: Hospitals 98
10.3. Asia-Pacific Poct Market: Clinics 101
10.4. Asia-Pacific Poct Market: Ambulatory Care 103
10.5. Asia-Pacific Poct Market: Home Healthcare 105
10.6. Asia-Pacific Poct Market: Research Laboratories 107
11. Asia-Pacific Point-Of-Care Testing Market, By Prescription Mode 109
11.1. Overview 110
11.2. Asia-Pacific Poct Market: Prescription Based Testing Kits 112
11.3. Asia-Pacific Poct Market: Over The Counter Based Testing Kits 115
12. Asia-Pacific Point-Of-Care Testing Market, By Geography 118
12.1. Asia-Pacific Point-Of-Care Testing Market 119
12.1.1. Japan Point-Of-Care Testing Market 131
12.1.2. China Point-Of-Care Testing Market 135
12.1.3. South Korea Point-Of-Care Testing Market 139
12.1.4. India Point-Of-Care Testing Market 143
12.1.5. Australia Point-Of-Care Testing Market 147
12.1.6. Singapore Point-Of-Care Testing Market 151
12.1.7. Thailand Point-Of-Care Testing Market 155
12.1.8. Malaysia Point-Of-Care Testing Market 159
12.1.9. Indonesia Point-Of-Care Testing Market 163
12.1.10. Philippines Point-Of-Care Testing Market 167
12.1.11. Rest Of Asia-Pacific Point-Of-Care Testing Market 171
12.2. Company Share Analysis: Asia-Pacific 173
13. Company Profiles 174
13.1. Johnson And Johnson Services, Inc. 174
13.1.1. Company Overview 174
13.1.2. Revenue Analysis 175
13.1.3. Product Portfolio 175
13.1.4. Recent Developments 175
13.2. Becton, Dickinson And Company 176
13.2.1. Company Overview 176
13.2.2. Revenue Analysis 177
13.2.3. Product Portfolio 177
13.2.4. Recent Developments 178
13.3. Medtronic 179
13.3.1. Company Overview 179
13.3.2. Revenue Analysis 180
13.3.3. Product Portfolio 180
13.3.4. Recent Developments 181
13.4. F. Hoffmann-La Roche Ltd 182
13.4.1. Company Overview 182
13.4.2. Revenue Analysis 182
13.4.3. Product Portfolio 183
13.4.4. Recent Developments 184
13.5. Siemens Ag 185
13.5.1. Company Overview 185
13.5.2. Revenue Analysis 185
13.5.3. Product Portfolio 186
13.5.4. Recent Developments 187
13.6. Abbott 188
13.6.1. Company Overview 188
13.6.2. Revenue Analysis 189
13.6.3. Product Portfolio 189
13.6.4. Product Pipeline 190
13.6.5. Recent Developments 191
13.7. Danaher 192
13.7.1. Company Overview 192
13.7.2. Revenue Analysis 193
13.7.3. Product Portfolio 194
13.7.4. Recent Developments 194
13.8. Werfenlife 195
13.8.1. Company Overview 195
13.8.2. Revenue Analysis 196
13.8.3. Product Portfolio 197
13.8.4. Recent Developments 197

13.9. Henry Schein, Inc. 198
13.9.1. Company Overview 198
13.9.2. Revenue Analysis 199
13.9.3. Product Portfolio 199
13.9.4. Recent Developments 201
13.10. Opti Medical (Subsidiary Of Idexx Laboratories, Inc) 202
13.10.1. Company Overview 202
13.10.2. Revenue Analysis 203
13.10.3. Product Portfolio 203
13.10.4. Recent Developments 204
13.11. Sienco, Inc. 205
13.11.1. Company Overview 205
13.11.2. Revenue Analysis 205
13.11.3. Product Portfolio 206
13.11.4. Recent Developments 206
13.12. Acon Laboratories, Inc. 207
13.12.1. Company Overview 207
13.12.2. Revenue Analysis 207
13.12.3. Product Portfolio 208
13.12.4. Recent Developments 209
13.13. Ativa Medical Corporation 210
13.13.1. Company Overview 210
13.13.2. Revenue Analysis 210
13.13.3. Product Portfolio 211
13.13.4. Recent Developments 211
13.14. Abaxis 212
13.14.1. Company Overview 212
13.14.2. Revenue Analysis 213
13.14.3. Product Portfolio 213
13.14.4. Recent Developments 214
13.15. Arkray, Inc 215
13.15.1. Company Overview 215
13.15.2. Revenue Analysis 215
13.15.3. Product Portfolio 216
13.15.4. Recent Developments 216
13.16. Aerscher Diagnostics, Llc 217
13.16.1. Company Overview 217
13.16.2. Revenue Analysis 217
13.16.3. Product Portfolio 218
13.16.4. Recent Developments 218
13.17. Artron Laboratories, Inc. 219
13.17.1. Company Overview 219
13.17.2. Revenue Analysis 219
13.17.3. Product Portfolio 220
13.17.4. Recent Developments 222
13.18. Biomerieux Sa 223
13.18.1. Company Overview 223
13.18.2. Revenue Analysis 224
13.18.3. Product Portfolio 225
13.18.4. Recent Developments 225
13.19. Entopsis 226
13.19.1. Company Overview 226
13.19.2. Revenue Analysis 226
13.19.3. Product Portfolio 227
13.19.4. Recent Developments 227

13.20. Lifesign, Llc. 228
13.20.1. Company Overview 228
13.20.2. Revenue Analysis 228
13.20.3. Product Portfolio 229
13.20.4. Recent Developments 229
14. Related Reports 230

Figures List

Figure 1 Asia-Pacific Point-Of-Care Testing Market: Segmentation
Figure 2 Asia-Pacific Point-Of-Care Testing Market: Geographic Scope
Figure 3 Asia-Pacific Point-Of-Care Testing Market: Data Triangulation
Figure 4 Asia-Pacific Point-Of-Care Testing Market Research Snapshot
Figure 5 Asia-Pacific Point-Of-Care Testing Market Bottom Up Approach
Figure 6 Asia-Pacific Point-Of-Care Testing Market Top Down Approach
Figure 7 Asia-Pacific Point-Of-Care Testing Market: Interview Demographics
Figure 8 Drivers, Restraints, Opportunities, And Challenges Of The Point-Of-Care Testing Market
Figure 9 Asia-Pacific Point-Of-Care Testing Market: Segmentation
Figure 10 Japan Is Expected To Dominate The Market For Point-Of-Care Testingand Chinais Expected To Be Growing With The Highest Cagr In The Forecast Period To 2024
Figure 11 High Prevalance Of Blood Glucose Are Expected To Drive The Market For Point-Of-Care Testing In The Forecast Period 2017 To 2024
Figure 12 Blood Glucose Testing Market Segment Is Expected To Account For The Largest Share Of The Point-Of-Care Testing Market In 2017 & 2024
Figure 13 Japan Is The Highest Growing And Most Profitable Revenue Pockets For Point-Of-Care Testing Manufacturers In The Forecast Period To 2024
Figure 14 Asia-Pacific Point-Of-Care Testing Market: By Type, Snapshot 2016
Figure 15 Asia-Pacific Poct Market: Cardiometabolic Monitoring Kits Market: By Product Segmentation
Figure 16 Asia-Pacific Poct Market: Infectious Disease Testing Kits Market: By Product
Figure 17 Asia-Pacific Poct Market: Cholestrol Testing Kits Market: By Product Segmentation
Figure 18 Asia-Pacific Poct Market: Blood Glucose Testing Kits Market: By Countries
Figure 19 Asia-Pacific Poct Market: Pregnancy And Fertility Testing Kits Market: By Countries
Figure 20 Asia-Pacificpoct Market: Tumor Cancer Markers Market: By Countries
Figure 21 Asia-Pacific Poct Market: Urinalysis Testing Kits Market: By Countries
Figure 22 Asia-Pacific Poct Market: Hematology Testing Kits Market: By Countries
Figure 23 Asia-Pacific Poct Market: Drugs Of Abuse Testing Kits Market: By Countries
Figure 24 Asia-Pacific Poct Market: Fecal Occult Testing Kits Market: By Region
Figure 25 Asia-Pacific Poct Market: Rapid Coagulation Testing Kitsmarket: By Region
Figure 26 Asia-Pacific Point-Of-Care Testing Market: By Distribution Channel, Snapshot 2016
Figure 27 Asia-Pacific Poct Market: Direct Tender Market: By Region
Figure 28 Retail Pharmacy Market: By Countries
Figure 29 Asia-Pacific Point-Of-Care Testing Market Dominated By Hospitals Segment
Figure 30 Asia-Pacific Point-Of-Care Testing Market:By End-User, Snapshot 2016
Figure 31 Asia-Pacific Poct Market: Hospitals; By Countries
Figure 32 Asia-Pacific Poct Market: Clinics; By Country
Figure 33 Asia-Pacific Poct Market: Ambulatory Care; By Country
Figure 34 Asia-Pacific Poct Market: Home Healthcare; By Country
Figure 35 Asia-Pacific Poct Market: Research Laboratory; By Country
Figure 36 Asia-Pacific Poct Market: Prescription Based Testing Kits; By Country
Figure 37 Asia-Pacific Poct Market: Over The Counter Based Testing Kits; By Country
Figure 38 Asia-Pacific Point-Of-Care Testing Market : Snapshot (2017)
Figure 39 Asia-Pacific Point-Of-Care Testing Market : By Country (2017)
Figure 40 Asia-Pacific Point-Of-Care Testing Market :By Product Type (2016 & 2024)
Figure 41 Asia-Pacific Point-Of-Care Testing Market: Company Share 2016 (%)

【レポートのキーワード】

POCT(ポイントオブケア検査)デバイス

★調査レポート[POCT(ポイントオブケア検査)デバイスのアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2024年)] (コード:DBMR810234)販売に関する免責事項を必ずご確認ください。
★調査レポート[POCT(ポイントオブケア検査)デバイスのアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2024年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆